Natalia Norori, Data & Evidence Manager at Prostate Cancer UK, delivers an insightful session on the importance of real-world data (RWD) in prostate cancer. This session is designed to equip healthcare professionals and researchers with a comprehensive understanding of how RWD can significantly impact prostate cancer research and clinical practice.
Throughout the session, Miss Norori covers fundamental aspects of real-world data, highlighting its significance in supplementing clinical trial data and providing insights into real-life patient experiences. Attendees will gain insights into the role of RWD in improving prostate cancer treatment strategies and enhancing patient outcomes through evidence-based practices.
The session also explores the challenges associated with collecting, analysing, and interpreting real-world data, addressing issues such as data quality, privacy concerns, and variability in data sources. Miss Norori provides recommendations and strategies for overcoming these challenges, offering practical guidance on how to leverage RWD effectively in prostate cancer research and clinical decision-making.
By the end of the session, participants will have a deeper appreciation for the potential of real-world data in driving advancements in prostate cancer care. They will be equipped with actionable insights to enhance their research methodologies, inform treatment decisions, and ultimately improve outcomes for patients.
This session is essential for healthcare professionals and researchers, involved in prostate cancer care and research, providing a foundational understanding of RWD and its transformative impact on prostate cancer management and patient care.
